ArticleHaematologica2025

Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome.

Serena De Matteis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.